Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
NCT06088030
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Pediatric Cancer
Li-Fraumeni Syndrome
p53 Mutations
Interventions
DRUG:
Arsenic trioxide
Sponsor
Yang Li
Collaborators
[object Object]